JP2023179556A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023179556A5 JP2023179556A5 JP2023160419A JP2023160419A JP2023179556A5 JP 2023179556 A5 JP2023179556 A5 JP 2023179556A5 JP 2023160419 A JP2023160419 A JP 2023160419A JP 2023160419 A JP2023160419 A JP 2023160419A JP 2023179556 A5 JP2023179556 A5 JP 2023179556A5
- Authority
- JP
- Japan
- Prior art keywords
- antibodies
- cancer
- derivatives
- use according
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/809,427 US11633506B2 (en) | 2016-07-18 | 2017-11-10 | Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunotherapies |
| US15/809,427 | 2017-11-10 | ||
| PCT/US2018/059927 WO2019094657A1 (en) | 2017-11-10 | 2018-11-09 | Using targeted radiotherapy (trt) to drive anti-tumor immune response to immunotherapies |
| JP2020525860A JP2021502368A (ja) | 2017-11-10 | 2018-11-09 | 免疫療法に対する抗腫瘍免疫応答を促進するための標的化放射線療法（ｔｒｔ）の使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020525860A Division JP2021502368A (ja) | 2017-11-10 | 2018-11-09 | 免疫療法に対する抗腫瘍免疫応答を促進するための標的化放射線療法（ｔｒｔ）の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023179556A JP2023179556A (ja) | 2023-12-19 |
| JP2023179556A5 true JP2023179556A5 (https=) | 2024-02-15 |
| JP7839135B2 JP7839135B2 (ja) | 2026-04-01 |
Family
ID=64665595
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020525860A Pending JP2021502368A (ja) | 2017-11-10 | 2018-11-09 | 免疫療法に対する抗腫瘍免疫応答を促進するための標的化放射線療法（ｔｒｔ）の使用 |
| JP2023160419A Active JP7839135B2 (ja) | 2017-11-10 | 2023-09-25 | 免疫療法に対する抗腫瘍免疫応答を促進するための標的化放射線療法（ｔｒｔ）の使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020525860A Pending JP2021502368A (ja) | 2017-11-10 | 2018-11-09 | 免疫療法に対する抗腫瘍免疫応答を促進するための標的化放射線療法（ｔｒｔ）の使用 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3706808A1 (https=) |
| JP (2) | JP2021502368A (https=) |
| KR (1) | KR102758660B1 (https=) |
| CN (2) | CN120550150A (https=) |
| AU (2) | AU2018366219B2 (https=) |
| CA (1) | CA3082056A1 (https=) |
| IL (2) | IL274518B1 (https=) |
| WO (1) | WO2019094657A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020132672A1 (en) * | 2018-12-21 | 2020-06-25 | Actinium Pharmaceuticals, Inc. | Combination of radioimmunotherapy and immune checkpoint therapy in the treatment of cancer |
| WO2021107689A1 (ko) * | 2019-11-27 | 2021-06-03 | (주)지아이이노베이션 | Il-2 단백질 및 cd80 단백질을 포함하는 융합단백질 및 면역관문 억제제를 포함하는 암 치료용 약학 조성물 |
| EP3842097A1 (en) * | 2019-12-23 | 2021-06-30 | Koninklijke Philips N.V. | Planning radiation therapy using a personalized hematologic risk score |
| JP2023512214A (ja) | 2020-01-28 | 2023-03-24 | リフレクション メディカル， インコーポレイテッド | 放射性核種および外部ビーム放射線療法の共同最適化 |
| JP2023519915A (ja) * | 2020-03-26 | 2023-05-15 | ラミレス－フォート，マリグダリア，カレス | 紫外線照射治療 |
| CN111840585B (zh) * | 2020-07-20 | 2022-05-03 | 厦门大学 | 一种用于肿瘤免疫治疗的药物组合 |
| US11964168B2 (en) | 2021-06-10 | 2024-04-23 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for prostate cancer |
| US20220395702A1 (en) * | 2021-06-10 | 2022-12-15 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for glioblastoma |
| US20230181790A1 (en) * | 2021-12-14 | 2023-06-15 | Boston Scientific Scimed Inc. | Radioactive shear thinning biomaterial composition and methods for use |
| WO2023141722A1 (en) * | 2022-01-28 | 2023-08-03 | Fusion Pharmaceuticals Inc. | Ntsr1-targeted radiopharmaceuticals and checkpoint inhibitor combination therapy |
| EP4727561A1 (en) * | 2023-06-16 | 2026-04-22 | Wisconsin Alumni Research Foundation | Treatment of solid tumors with a regimen of targeted radionuclide therapy and genetically engineered immune cell therapies |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7226577B2 (en) * | 2003-01-13 | 2007-06-05 | Bracco Imaging, S. P. A. | Gastrin releasing peptide compounds |
| US8540968B2 (en) | 2004-03-02 | 2013-09-24 | Cellectar, Inc. | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof |
| KR20070015518A (ko) * | 2004-03-02 | 2007-02-05 | 셀렉타, 엘엘씨 | 암의 진단 및 치료를 위한 포스포리피드 유사체 |
| KR20080005178A (ko) * | 2004-12-20 | 2008-01-10 | 셀렉타, 엘엘씨 | 암 검출 및 치료용 인지질 에테르 동족체 |
| SI3708192T1 (sl) * | 2009-06-12 | 2023-12-29 | Cellectar, Inc. | Eter fosfolipidne spojine za zdravljenje raka in slikanje in detekcijo rakavih izvornih celic |
| JP2018518526A (ja) * | 2015-06-25 | 2018-07-12 | アドバンスド アクセレレーター アプリケーションズ | ソマトスタチン受容体を過剰発現する神経内分泌腫瘍を処置する方法 |
| WO2017025496A1 (en) * | 2015-08-12 | 2017-02-16 | Bayer Pharma Aktiengesellschaft | Pharmaceutical combination for the treatment of cancer |
| CN108430520B (zh) * | 2015-11-06 | 2021-08-13 | 威斯康星校友研究基金会 | 长效钆基肿瘤靶向成像与治疗剂 |
| EP3252268A1 (en) * | 2016-06-02 | 2017-12-06 | Welltec A/S | Downhole power supply device |
| US11633506B2 (en) * | 2016-07-18 | 2023-04-25 | Wisconsin Alumni Research Foundation | Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunotherapies |
| EP3484513B1 (en) * | 2016-07-18 | 2023-06-07 | Wisconsin Alumni Research Foundation | Radiohalogenated agents for combined cancer therapy |
| JP7127014B2 (ja) | 2016-07-25 | 2022-08-29 | ウイスコンシン アラムナイ リサーチ ファウンデーシヨン | 癌のイメージングおよび治療のための放射性リン脂質金属キレート |
| IL264365B2 (en) * | 2016-07-25 | 2026-03-01 | Wisconsin Alumni Res Found | Chelates for targeted radiotherapy for in situ immune-modulated cancer vaccination |
-
2018
- 2018-11-09 KR KR1020207016410A patent/KR102758660B1/ko active Active
- 2018-11-09 EP EP18819480.7A patent/EP3706808A1/en active Pending
- 2018-11-09 IL IL274518A patent/IL274518B1/en unknown
- 2018-11-09 JP JP2020525860A patent/JP2021502368A/ja active Pending
- 2018-11-09 WO PCT/US2018/059927 patent/WO2019094657A1/en not_active Ceased
- 2018-11-09 AU AU2018366219A patent/AU2018366219B2/en active Active
- 2018-11-09 CA CA3082056A patent/CA3082056A1/en active Pending
- 2018-11-09 CN CN202510688757.2A patent/CN120550150A/zh active Pending
- 2018-11-09 CN CN201880086000.4A patent/CN111565762A/zh active Pending
-
2023
- 2023-09-25 JP JP2023160419A patent/JP7839135B2/ja active Active
-
2025
- 2025-11-19 AU AU2025271049A patent/AU2025271049A1/en active Pending
- 2025-12-28 IL IL325659A patent/IL325659A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023179556A5 (https=) | ||
| JP7839135B2 (ja) | 免疫療法に対する抗腫瘍免疫応答を促進するための標的化放射線療法（ｔｒｔ）の使用 | |
| Wang et al. | Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response | |
| US20230398239A1 (en) | Using Targeted Radiotherapy (TRT) to Drive Anti-Tumor Immune Response to Immunotherapies | |
| CN109310763B (zh) | 用于癌症免疫疗法的受体选择性类视黄醇和rexinoid化合物和免疫调节剂 | |
| US20180360962A1 (en) | Combination of dr5 agonist and anti-pd-1 antagonist and methods of use | |
| RS64014B1 (sr) | Postupci lečenja kancera kože davanjem inhibitora pd-1 | |
| BRPI0607486B1 (pt) | Anticorpo humanizado l243 contra hla-dr presente nas células hladr+,composição farmacêutica, kit e uso dos referidos anticorpos. | |
| US20260053963A1 (en) | Radioconjugates targeting cd33 in the treatment of breast cancer | |
| US20220143228A1 (en) | Her3 radioimmunotherapy for the treatment of solid cancers | |
| TW202131946A (zh) | 持續性免疫療法 | |
| JP7154634B2 (ja) | 腫瘍免疫賦活剤 | |
| Awuah et al. | Sequential CAR T cell and targeted alpha immunotherapy in disseminated multiple myeloma | |
| WO2020083982A1 (en) | Guanabenz as an adjuvant for immunotherapy | |
| US12539340B2 (en) | Radioconjugates targeting CD33 in the treatment of cancers | |
| EP4380632A1 (en) | Radioconjugates targeting cd33 in the treatment of cancers | |
| EP4247430A1 (en) | Her3 radioimmunotherapy for the treatment of solid cancers | |
| US12551584B1 (en) | Lewis Y radioimmunotherapy for the treatment of cancer | |
| JP2023538568A (ja) | がん治療における使用のためのｌｆａ－１シグナル伝達メディエーター | |
| HK40081237A (en) | Receptor selective retinoid and rexinoid compounds and immune modulators for cancer immunotherapy | |
| JP2024544518A (ja) | 癌治療のためのｔｌｒ７アゴニストおよび組合せ | |
| CN120302979A (zh) | 针对CD40和CD137的多特异性抗体与抗PD1 Ab和化学治疗的组合治疗 | |
| WO2022046792A2 (en) | Methods and compositions for genetic modulation of tumor microenvironments | |
| HK1260468A1 (en) | Receptor selective retinoid and rexinoid compounds and immune modulators for cancer immunotherapy | |
| CN110352199A (zh) | 免疫检查点治疗 |